Related Experiment Video
Updated: Jun 4, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic shock: role of revascularization
M M Vis1, J J Piek, J P S Henriques
1Department of Cardiology, Academic Medical Center, Amsterdam, the Netherlands.
Minerva Cardioangiologica
|February 3, 2011
Summary
Cardiogenic shock (CS), often caused by myocardial ischemia during heart attacks, affects about 7% of STEMI patients. Early revascularization, particularly primary PCI, is key, though outcomes remain challenging with high mortality.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI), with ST-segment elevation myocardial infarction (STEMI) patients experiencing an incidence of around 7%.
- Despite advancements, in-hospital mortality for CS remains high at approximately 50%.
Purpose of the Study:
- To review the current understanding and management strategies for cardiogenic shock in the context of acute myocardial infarction.
- To highlight the importance of early diagnosis, revascularization, and emerging therapeutic options.
Main Methods:
- Review of existing literature and guidelines on cardiogenic shock management.
- Analysis of treatment efficacy, including percutaneous coronary intervention (PCI) and surgical options.
- Discussion of hemodynamic support devices and their potential impact.
Main Results:
- Early revascularization, especially primary PCI, is the cornerstone treatment for AMI complicated by CS, recommended within 36 hours of onset and 18 hours of diagnosis.
- Staged PCI or coronary artery bypass grafting (CABG) may be preferred for CS patients with significant left main or three-vessel disease.
- New percutaneous left ventricular unloading devices show promise in preserving vital organ perfusion.
Conclusions:
- Despite high mortality, long-term quality of life for CS survivors is comparable to AMI patients without CS.
- A multi-faceted approach involving early diagnosis, timely revascularization, and advanced hemodynamic support is crucial for improving CS outcomes.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...